Rocket Pharmaceuticals
Price & Volume
Stats
See more52W Range | $2.19-$8.26 |
Market Cap | $378.9M |
Shares Short | 18M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.01 |
News
See moreYahoo Finance • 14 days ago
Wedbush Reaffirms Rocket Pharma At Outperform With $16 Price Target
Yahoo Finance • 14 days ago
Why Rocket Pharmaceuticals (RCKT) Got a Commercial Boost From FDA Approval of KRESLADI
Yahoo Finance • 5 months ago
Fanconi Anemia Market Research Report 2025-2035: Competitive Growth Driven by Rocket Pharmaceuticals, Foresee, Merck, and Abeona as Gene Therapy and CRISPR-Based Innovations Expand
Yahoo Finance • 5 months ago
Rocket Pharmaceuticals, Inc. Q3 Loss Decreases, Beats Estimates
About
CEO | Dr. Gaurav D. Shah M.D. |
Address | 9 Cedarbrook Drive, Cranbury, NJ, United States, 08512 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 202 |
